about
Nicotine receptor partial agonists for smoking cessationOrthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking CessationSmoking cessation and the cardiovascular patientHealth-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline developmentThe Past, Present, and Future of Nicotine Addiction TherapyNew Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?Strategies to promote smoking cessation among adolescents.Tobacco intervention research in low- and middle-income countries: lessons learned and future directions.Updates in the management of stable chronic obstructive pulmonary disease.Updated evidence-based guide to smoking cessation therapies.Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.The COPD Pipeline, XXVI.Systematic integration of biomedical knowledge prioritizes drugs for repurposing.Which Environmental Factors Cause IBD Relapses?Cytisine inhibits the protective activity of various classical and novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.Des stratégies pour promouvoir l’abandon du tabac chez les adolescents.Plasma concentrations of cytisine, a commercially available plant-based alkaloid, in healthy adult smokers taking recommended doses for smoking cessation.Getting cytisine licensed for use world-wide: a call to action.The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients - protocol for a double-blind, placebo-controlled randomised trial.Protocol for the mixed-methods process and context evaluation of the TB & Tobacco randomised controlled trial in Bangladesh and Pakistan: a hybrid effectiveness-implementation study.
P2860
Q24185773-52E563F4-DB3D-43A4-B459-F98115DB3FDCQ26774830-CEE246D0-6466-4599-B3CB-2BC4EB91B815Q28082695-B45D8A80-A8C5-4A33-9A6B-C7D6255A6642Q28086911-3A9DBC6E-6F95-495E-BB74-B4AD1842D029Q28088508-53A24ECC-CC24-487C-BE41-56146A85994BQ28277165-9949AB22-A9A6-4780-835F-5FE84C2BE7AAQ37068346-95E1B749-A6B0-4974-AEC4-93AC596D6E94Q37718533-9B0A3BC4-722E-4683-9B44-0F6FA1C1CB8FQ38578596-71DB1B46-8122-4749-9956-8911E37C0FF4Q39030638-4623AACD-E266-4B25-873C-3FE1DCC6E2BBQ39365144-75BA6343-C4D2-484B-8C8D-21470A3CAAD5Q41398563-18AC5B87-1827-412F-AE49-9BA542EABA78Q42255083-4B3C2AA7-ACED-4F68-A0FF-A7A7F8F4D02FQ43561064-97ADD727-7D9A-47D6-A8EC-AB43936E4B70Q44225611-1F394433-DD1B-439E-A6AC-A6512860EF87Q46846384-08CD065A-9A2E-4E73-9DCB-B140BFD47170Q47423873-EC8937F9-77E7-4373-8D1E-6CF31FBD5F4BQ48156268-5D3B5AF0-3B8B-4068-BAF6-E3C2C9AA2005Q52574704-91D6B73B-C37F-48F5-A772-67FD07A9E1E1Q52802384-BC5D6E37-0A8A-4B31-9EB2-825BFF253096
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cytisine versus nicotine for smoking cessation
@ast
Cytisine versus nicotine for smoking cessation
@en
Cytisine versus nicotine for smoking cessation
@nl
type
label
Cytisine versus nicotine for smoking cessation
@ast
Cytisine versus nicotine for smoking cessation
@en
Cytisine versus nicotine for smoking cessation
@nl
prefLabel
Cytisine versus nicotine for smoking cessation
@ast
Cytisine versus nicotine for smoking cessation
@en
Cytisine versus nicotine for smoking cessation
@nl
P2093
P50
P356
P1476
Cytisine versus nicotine for smoking cessation
@en
P2093
Bruce Bassett
Colin Howe
Hayden McRobbie
Natalie Walker
Varsha Parag
P304
P356
10.1056/NEJMOA1407764
P407
P577
2014-12-18T00:00:00Z